Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Reprod Toxicol ; 23(4): 532-40, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17418525

RESUMO

The objectives of this study were to assess the potential for D(4) to suppress the pre-ovulatory lutenizing hormone (LH) surge, to block or delay ovulation, and to evaluate potential effects on reproductive hormones in rats. Female Sprague-Dawley Crl:CD (SD) IGS BR rats received whole-body vapor inhalation exposure to D(4) (0, 700, or 900ppm) 6h per day for 3 days. Trunk blood obtained on proestrus at 10a.m. was evaluated for levels of follicle stimulating hormone (FSH), estradiol (E2), estrone (E1), and progesterone (P4). Other rats had serial blood samples collected via cannula at 2, 4, 6, 8, and 10p.m. on the day of proestrus and plasma evaluated for LH and prolactin (PRL). Trunk blood was collected at 8a.m. of estrus and plasma evaluated for FSH, E2, E1, and P4. At 10a.m. on proestrus, significant increases in E1 levels in the 700 and 900ppm groups and significant increases in P4 levels in the 900ppm group were noted. At 8a.m. on estrus, significant increases in E1, E2, in the E1/E2 ratio and decreases in FSH were noted in the 700 and 900ppm groups. The major effect on the LH profile was observed most clearly when the rats were grouped by ovulatory status, animals that did or did not ovulate. Regardless of treatment, suppression of the LH surge correlated with blocked ovulation. The percentage of rats that ovulated was (700ppm, 42%; 900ppm, 31%) compared to controls (79%). Overall, the data indicate that high exposures to D(4) attenuated the pre-ovulatory LH surge and significantly decreased the portion of female rats that ovulated.


Assuntos
Poluentes Atmosféricos/toxicidade , Disruptores Endócrinos/toxicidade , Ciclo Estral/efeitos dos fármacos , Exposição por Inalação , Hormônio Luteinizante/sangue , Ovulação/efeitos dos fármacos , Siloxanas/toxicidade , Poluentes Atmosféricos/química , Animais , Peso Corporal/efeitos dos fármacos , Encéfalo/efeitos dos fármacos , Encéfalo/patologia , Relação Dose-Resposta a Droga , Disruptores Endócrinos/química , Estradiol/sangue , Estrona/sangue , Ciclo Estral/sangue , Feminino , Hormônio Foliculoestimulante/sangue , Tamanho do Órgão/efeitos dos fármacos , Ovário/efeitos dos fármacos , Ovário/patologia , Ovulação/sangue , Óvulo/efeitos dos fármacos , Óvulo/patologia , Progesterona/sangue , Prolactina/sangue , Ratos , Ratos Sprague-Dawley , Siloxanas/química , Fatores de Tempo , Útero/efeitos dos fármacos , Útero/patologia , Volatilização
2.
Toxicol Pathol ; 30(5): 570-9, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12371666

RESUMO

A series of inhalation studies with propylene glycol monomethyl ether (PGME) vapor were undertaken to characterize its subchronic toxicity in mice and chronic toxicity/oncogenicity in rats and mice. Groups of male and female Fischer 344 rats and B6C3F1 mice were exposed to 0, 300, 1,000, or 3,000 ppm vapor from 1 week to 2 years. Primary treatment-related effects included: initial sedation of animals exposed to 3,000 ppm and its subsequent resolution correlating with induction of hepatic mixed function oxidase activity and S-phase DNA synthesis; elevated mortality in high-exposure male rats and mice (chronic study); elevated deposition of alpha2u-globulin (alpha2U-G) and associated nephropathy and S-phase DNA synthesis in male rat kidneys; accelerated atrophy of the adrenal gland X-zone in female mice (subchronic study only); and increased occurrence and/or severity of eosinophilic foci of altered hepatocytes in male rats. No toxicologically relevant statistically significant increases in neoplasia occurred in either species. A numerical increase in the incidence of kidney adenomas occurred in intermediate-exposure male rats; however, the association with alpha2U-G nephropathy, a male rat specific effect, indicated a lack of relevance for human risk assessment.


Assuntos
Carcinógenos/toxicidade , Neoplasias/etiologia , Propilenoglicóis/toxicidade , Adenoma/induzido quimicamente , Adenoma/metabolismo , Adenoma/patologia , Administração por Inalação , alfa-Globulinas/metabolismo , Animais , Testes de Carcinogenicidade , Carcinógenos/administração & dosagem , DNA/biossíntese , Replicação do DNA/efeitos dos fármacos , Relação Dose-Resposta a Droga , Indução Enzimática/efeitos dos fármacos , Feminino , Neoplasias Renais/induzido quimicamente , Neoplasias Renais/metabolismo , Neoplasias Renais/patologia , Fígado/efeitos dos fármacos , Fígado/enzimologia , Longevidade/efeitos dos fármacos , Masculino , Camundongos , Camundongos Endogâmicos , Oxigenases de Função Mista/biossíntese , Neoplasias/patologia , Propilenoglicóis/administração & dosagem , Ratos , Ratos Endogâmicos F344 , Fase S/efeitos dos fármacos , Fase S/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA